(2R,3R,4R,5R)-2,5-bis(3-bromobenzyloxy)-3,4-dihydroxy-N1-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-N6-((R)-3-oxo-2,3-dihydro-1H-inden-1-yl)hexanediamide

ID: ALA5286957

Max Phase: Preclinical

Molecular Formula: C38H36Br2N2O8

Molecular Weight: 808.52

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C[C@@H](NC(=O)[C@H](OCc2cccc(Br)c2)[C@H](O)[C@@H](O)[C@@H](OCc2cccc(Br)c2)C(=O)N[C@H]2c3ccccc3C[C@H]2O)c2ccccc21

Standard InChI:  InChI=1S/C38H36Br2N2O8/c39-24-10-5-7-21(15-24)19-49-35(37(47)41-29-18-30(43)28-14-4-3-13-27(28)29)33(45)34(46)36(50-20-22-8-6-11-25(40)16-22)38(48)42-32-26-12-2-1-9-23(26)17-31(32)44/h1-16,29,31-36,44-46H,17-20H2,(H,41,47)(H,42,48)/t29-,31-,32+,33-,34-,35-,36-/m1/s1

Standard InChI Key:  VAUCVBVDKMBJNL-LJMFFZSVSA-N

Molfile:  

 
     RDKit          2D

 50 55  0  0  0  0  0  0  0  0999 V2000
    2.0009  -17.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6101  -17.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3519  -16.9287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5482  -16.7611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0585  -18.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2510  -18.1573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8404  -18.8731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940  -19.4848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1469  -19.1471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0232  -18.9610    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8598  -19.5561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5703  -19.1432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2832  -19.5523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5681  -18.3215    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2854  -20.3741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9937  -19.1393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7066  -19.5484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9916  -18.3175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7088  -20.3702    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4173  -19.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5747  -20.7869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5770  -21.6087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8644  -22.0184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8662  -22.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5796  -23.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2926  -22.8321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2872  -22.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1554  -23.2520    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.1300  -19.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4150  -18.3137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1256  -17.9009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1234  -17.0791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8345  -16.6723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8326  -15.8512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1192  -15.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4063  -15.8587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4117  -16.6783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5435  -15.4387    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.1322  -20.3664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8407  -19.1318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5535  -19.5407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8593  -19.8121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3076  -19.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4503  -20.5251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6496  -20.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1056  -20.9653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3611  -21.7422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1654  -21.9072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7060  -21.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4764  -18.3987    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0
  5  2  2  0
  2  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
  9 11  1  6
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  1
 13 16  1  0
 16 17  1  0
 16 18  1  6
 17 19  1  6
 17 20  1  0
 15 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 24 28  1  0
 20 29  1  0
 20 30  1  1
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 34 38  1  0
 29 39  2  0
 29 40  1  0
 41 40  1  6
 41 45  1  0
 44 42  1  0
 42 43  1  0
 43 41  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 44  1  0
 43 50  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5286957

    ---

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 protease (9113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 808.52Molecular Weight (Monoisotopic): 806.0838AlogP: 4.62#Rotatable Bonds: 13
Polar Surface Area: 154.42Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.86CX Basic pKa: CX LogP: 4.49CX LogD: 4.49
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.13Np Likeness Score: 0.19

References

1. Ghosh AK, Osswald HL, Prato G..  (2016)  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.,  59  (11): [PMID:26799988] [10.1021/acs.jmedchem.5b01697]

Source